Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Green Cross Health Among 3 Penny Stocks Worth Watching

In This Article:

Global markets have experienced a turbulent week, with U.S. stocks facing volatility due to AI competition fears and mixed corporate earnings reports, while European indices hit record highs following the ECB's rate cut. Amid these fluctuating conditions, investors often seek opportunities in less conventional areas of the market. Penny stocks, though an older term, continue to hold relevance for those interested in smaller or newer companies that offer potential value and growth. This article will explore three penny stocks that stand out for their financial strength and potential to deliver significant returns over time.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

Bosideng International Holdings (SEHK:3998)

HK$3.69

HK$42.39B

★★★★★★

DXN Holdings Bhd (KLSE:DXN)

MYR0.525

MYR2.61B

★★★★★★

Datasonic Group Berhad (KLSE:DSONIC)

MYR0.395

MYR1.1B

★★★★★★

Polar Capital Holdings (AIM:POLR)

£4.89

£482.95M

★★★★★★

MGB Berhad (KLSE:MGB)

MYR0.70

MYR414.16M

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.88

MYR285.47M

★★★★★★

Tristel (AIM:TSTL)

£3.65

£178.85M

★★★★★★

Lever Style (SEHK:1346)

HK$1.10

HK$698.27M

★★★★★★

Embark Early Education (ASX:EVO)

A$0.79

A$144.95M

★★★★☆☆

China Lilang (SEHK:1234)

HK$3.92

HK$4.69B

★★★★★☆

Click here to see the full list of 5,728 stocks from our Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Green Cross Health

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Green Cross Health Limited operates in New Zealand, offering healthcare and advice services to communities, with a market cap of NZ$114.88 million.

Operations: The company generates revenue through its Medical Services segment, which contributes NZ$149.29 million, and its Pharmacy Services segment, which accounts for NZ$364.32 million.

Market Cap: NZ$114.88M

Green Cross Health Limited, with a market cap of NZ$114.88 million, shows mixed results in its financial health and growth prospects. The company reported half-year sales of NZ$259.88 million, reflecting slight growth from the previous year, but earnings have declined by 3.1% annually over five years. While it maintains high-quality earnings and satisfactory debt management with net debt to equity at 3.4%, its short-term assets fall short of covering liabilities, indicating potential liquidity challenges. The board and management are experienced; however, the share price has been volatile recently and dividends remain unstable despite recent payouts.